Clinical features of long-term survivors with advanced high-grade serous ovarian cancer.

被引：0
|
作者：
Barretina-Ginesta, Maria-Pilar
Bague, Anna Carbo
Bujons, Elisabet
Fortian, Arola
Fina, Claudia
Pardo, Marta
Melendez-Munoz, Cristina
Cardenas, Laura
Taltavull, Anna
Sabate, Josep
Darder, Esther
Feliubadalo, Lidia
Barretina, Jordi
Brunet, Joan
机构：
[1] Catalan Inst Oncol, Med Oncol, Girona, Spain
[2] Univ Girona, Girona Biomed Res Inst, Sch Med, Girona, Spain
[3] Catalan Inst Oncol, Dept Med Oncol, Girona, Spain
[4] Hosp Univ Dr Josep Trueta, Girona, Spain
[5] Inst Recerca Germans Trias & Pujol, Badalona, Spain
[6] Inst Invest Biomed Girona, Girona, Spain
[7] Hosp Univ Dr Josep Trueta, Dept Pathol, Girona, Spain
[8] Hosp Univ Dr Josep Trueta, Dept Gynecol, Girona, Spain
[9] IDIBGI, Hereditary Canc Program, Catalan Inst Oncol, Girona, Spain
[10] IDIBELL, Hereditary Canc Program, Catalan Inst Oncol, Lhospitalet De Llobregat, Spain
[11] Girona Biomed Res Inst IDIBGi, Girona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17575
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The genomic landscape of high-grade serous ovarian cancer in long-term survivors
    Garsed, Dale W.
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje C.
    Saner, Flurina
    Beach, Jessica A.
    Milne, Katy
    Kennedy, Catherine J.
    Hendley, Joy
    Traficante, Nadia
    Pearce, Celeste L.
    Pike, Malcolm C.
    Ramus, Susan J.
    Kobel, Martin
    Nelson, Brad H.
    Goode, Ellen L.
    deFazio, Anna
    Bowtell, David D.
    CANCER RESEARCH, 2019, 79 (13)
  • [2] The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
    Garsed, Dale W.
    Pandey, Ahwan
    Fereday, Sian
    Kennedy, Catherine J.
    Takahashi, Kazuaki
    Alsop, Kathryn
    Hamilton, Phineas T.
    Hendley, Joy
    Chiew, Yoke-Eng
    Traficante, Nadia
    Provan, Pamela
    Ariyaratne, Dinuka
    Au-Yeung, George
    Bateman, Nicholas W.
    Bowes, Leanne
    Brand, Alison
    Christie, Elizabeth L.
    Cunningham, Julie M.
    Friedlander, Michael
    Grout, Bronwyn
    Harnett, Paul
    Hung, Jillian
    McCauley, Bryan
    McNally, Orla
    Piskorz, Anna M.
    Saner, Flurina A. M.
    Vierkant, Robert A.
    Wang, Chen
    Winham, Stacey J.
    Pharoah, Paul D. P.
    Brenton, James D.
    Conrads, Thomas P.
    Maxwell, George L.
    Ramus, Susan J.
    Pearce, Celeste Leigh
    Pike, Malcolm C.
    Nelson, Brad H.
    Goode, Ellen L.
    DeFazio, Anna
    Bowtell, David D. L.
    NATURE GENETICS, 2022, 54 (12) : 1853 - 1864
  • [3] The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
    Dale W. Garsed
    Ahwan Pandey
    Sian Fereday
    Catherine J. Kennedy
    Kazuaki Takahashi
    Kathryn Alsop
    Phineas T. Hamilton
    Joy Hendley
    Yoke-Eng Chiew
    Nadia Traficante
    Pamela Provan
    Dinuka Ariyaratne
    George Au-Yeung
    Nicholas W. Bateman
    Leanne Bowes
    Alison Brand
    Elizabeth L. Christie
    Julie M. Cunningham
    Michael Friedlander
    Bronwyn Grout
    Paul Harnett
    Jillian Hung
    Bryan McCauley
    Orla McNally
    Anna M. Piskorz
    Flurina A. M. Saner
    Robert A. Vierkant
    Chen Wang
    Stacey J. Winham
    Paul D. P. Pharoah
    James D. Brenton
    Thomas P. Conrads
    George L. Maxwell
    Susan J. Ramus
    Celeste Leigh Pearce
    Malcolm C. Pike
    Brad H. Nelson
    Ellen L. Goode
    Anna DeFazio
    David D. L. Bowtell
    Nature Genetics, 2022, 54 : 1853 - 1864
  • [4] What influences the long-term survival of advanced high-grade serous ovarian cancer?
    Xie, X.
    Jin, L.
    Tang, S.
    Shen, Y.
    Cheng, X.
    Lv, W.
    Wan, X.
    Chen, Z.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 347 - 347
  • [5] Who are the long-term survivors of high grade serous ovarian cancer?
    Hoppenot, Claire
    Eckert, Mark A.
    Tienda, Samantha M.
    Lengyel, Ernst
    GYNECOLOGIC ONCOLOGY, 2018, 148 (01) : 204 - 212
  • [6] Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer
    Fabbro, Michel
    Colombo, Pierre-Emmanuel
    Leaha, Cristina Marinella
    Rouanet, Philippe
    Carrere, Sebastien
    Quenet, Francois
    Gutowski, Marian
    Mourregot, Anne
    D'Hondt, Veronique
    Coupier, Isabelle
    Vendrell, Julie
    Vilquin, Paul
    Pujol, Pascal
    Solassol, Jerome
    Mollevi, Caroline
    CANCERS, 2020, 12 (08) : 1 - 14
  • [7] Immune-molecular interactions in high-grade serous ovarian cancer distinguish long-term survivors
    Boudreau, Jeanette E.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (24):
  • [8] Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization
    Lheureux, Stephanie
    Lai, Zhongwu
    Dougherty, Brian A.
    Runswick, Sarah
    Hodgson, Darren R.
    Timms, Kirsten M.
    Lanchbury, Jerry S.
    Kaye, Stan
    Gourley, Charlie
    Bowtell, David
    Kohn, Elise C.
    Scott, Claire
    Matulonis, Ursula
    Panzarella, Tony
    Karakasis, Katherine
    Burnier, Julia V.
    Gilks, C. Blake
    O'Connor, Mark J.
    Robertson, Jane D.
    Ledermann, Jonathan
    Barrett, J. Carl
    Ho, Tony W.
    Oza, Amit M.
    CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4086 - 4094
  • [9] Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients
    Clarke, Christina L.
    Kushi, Lawrence H.
    Chubak, Jessica
    Pawloski, Pamala A.
    Bulkley, Joanna E.
    Epstein, Mara M.
    Burnett-Hartman, Andrea N.
    Powell, Bethan
    Pearce, Celeste L.
    Feigelson, Heather Spencer
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (05) : 996 - 999
  • [10] Protein anabolism is key to long-term survival in high-grade serous ovarian cancer
    Wang, Lingxiang
    Sun, Tao
    Li, Shumei
    Zhang, Zhengmao
    Jia, Jingde
    Shan, Baoen
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
12345